U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06867900) titled 'Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives' on July 06, 2023.
Brief Summary: Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.
Study Start Date: Jan. 01, 2021
Study Type: INTERVENTIONAL
Condition:
Miscarriage, Recurrent
Intervention:
DIETARY_SUPPLEMENT: Bifidobacterium Longum ES1
Oral administration of Bifidobacterium Longum ES1 for three months.
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Published by HT Digita...